Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Hercules Capital, Inc. Common Stock (NY:HTGC)

16.83 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Apr 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hercules Capital, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Hercules Capital Announces Date of 2022 Annual Meeting of Stockholders
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Reports First Quarter 2022 Financial Results
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Announces Supplemental Cash Distribution of $0.15 per Share for the First Quarter of 2022
From Hercules Capital, Inc.
Via Business Wire
Is This 10.7% Yield Too Strong for Its Own Good?
Hercules Capital’s dividend situation is a bit unique because it regularly pays a variable supplemental dividend in addition to its quarterly dividend. 
Via Talk Markets
Earnings Scheduled For February 22, 2022
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million. • Sohu... 
Via Benzinga
Hercules Capital Declares Cash Distribution of $0.33 per Share for the First Quarter of 2022
From Hercules Capital, Inc.
Via Business Wire
Expert Ratings for Hercules Capital
Over the past 3 months, 4 analysts have published their opinion on Hercules Capital (NYSE:HTGC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Hercules Receives a BBB Reaffirmed Investment Grade Corporate Rating From DBRS, Inc.
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Announces Date for Release of First Quarter 2022 Financial Results and Conference Call
From Hercules Capital, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 22, 2022
Upgrades 
Via Benzinga
The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2022
Upgrades 
Via Benzinga
Grow Your Dividend Income Despite Inflation And Rate Hikes
High inflation has become a driving force in our lives. It’s challenging to invest for income and keep up with inflation, especially outside of commodity-focused investments. 
Via Talk Markets
Hercules Cap: Q4 Earnings Insights
Hercules Cap (NYSE:HTGC) reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
Hercules Capital Reports Fourth Quarter and Full-Year 2021 Financial Results
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Announces New Supplemental Cash Distribution of $0.60 per Share
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Declares Cash Distribution of $0.33 per Share for the Fourth Quarter of 2021
From Hercules Capital, Inc.
Via Business Wire
AI-Enabled Esme Learning Solutions Raises Up to $15 Million From Hercules Capital
Workforce transformation pioneer marks third anniversary with new investment partner bringing total investment to date hitting $38.5m. New round of growth funding sets up Esme's AI platform for further... 
Via Newswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
Benzinga's Top Ratings Upgrades, Downgrades For February 8, 2022
Upgrades According to Consumer Edge Research, the prior rating for The Hain Celestial Group Inc (NASDAQ:HAIN) was changed from Equal-Weight to Overweight. For the second... 
Via Benzinga
Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2021 Financial Results and Conference Call
From Hercules Capital, Inc.
Via Business Wire
Stock Wars: Axsome Therapeutics Vs. Global Blood Therapeutics
Benzinga’s weekly Stock Wars matches up two leaders in a major industry sector with the goal of determining which company is the better investment. 
Via Benzinga
Hercules Capital Enhances C-Suite for Future Growth
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Closes Upsized Public Offering of $350.0 Million 3.375% Notes Due 2027
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Prices Upsized Public Offering of $350.0 Million 3.375% Notes due 2027
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Surpasses $2.0 Billion in Annual Gross Debt and Equity Commitments for First Time in History
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Further Strengthens Its Capital Resources With New $100.0 Million Multi-Currency Credit Facility
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Announces Upcoming Events for the Financial Community
From Hercules Capital, Inc.
Via Business Wire
Hercules Technology Growth Capital (HTGC) Q3 2021 Earnings Call Transcript
HTGC earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Hercules Capital Reports Third Quarter 2021 Financial Results
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Announces Supplemental Cash Distribution of $0.07 per Share for the Third Quarter of 2021
From Hercules Capital, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.